Effects of antihypertensive drugs on renal function after percutaneous transluminal coronary angioplasty
10.12206/j.issn.1006-0111.202101020
- VernacularTitle:经皮冠状动脉腔内成形术后应用降压药对肾功能的影响
- Author:
Huiyan JIANG
1
;
Simin YAN
1
;
Weihong GE
1
Author Information
1. Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing 210008, China.
- Keywords:
percutaneous transluminal coronary angioplasty;
contrast-induced nephropathy;
angiotensin convening enzyme inhibitor;
angiotensin receptor blockers;
β-blockers;
calcium channel blockers
- From:
Journal of Pharmaceutical Practice
2022;40(1):89-92
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effects of antihypertensive drugs on renal function after percutaneous transluminal coronary angioplasty. Methods A retrospective analysis was performed on 193 patients who underwent percutaneous transluminal coronary angioplasty and took antihypertensive drugs regularly. Those patients were admitted to Nanjing Drum Tower Hospital during January 2020 to December 2020. The patients were divided into ACEI/ARB group, β-blockers, calcium channel blockers and hydration control group. All patients received routine hydration during the perioperative period. The changes of serum creatinine (Scr), blood urea nitrogen (BUN), estimated glomerular filtration rate(eGFR) and endogenous creatinine clearance rate (Ccr) before and after operation were compared. Results The incidence of CIN was 0% in four groups. Compared with the preoperative, there was no significant change in Scr and Ccr in every group. Except for the hydration control group, the BUN levels in three treated groups were reduced after postoperative. Specifically, the BUN reduction in β-blockers group has statistically significant difference compared to the hydration control group and CCB group. In addition, eGFR levels were significantly reduced in the β-blockers group. Preoperative Scr and Ccr levels in patients with high blood pressure (SBP≥140 or DBP≥90) were significantly different from the patients with normal blood pressure (SBP<140 and DBP<90). Conclusion The use of ACEI/ARB and CCB before percutaneous transluminal coronary angioplasty had no effect on renal function in the short term. β-blockers can slightly reduce renal function, especially in patients with high blood pressure, who should receive special attention.
